"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."

During the past decade, Kaiser Permanente-San Diego Zion conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 50 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 33 clinical trials were completed. i.e. 206.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-San Diego Zion" #1 sponsor was "National Cancer Institute (NCI)" with 67 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-San Diego Zion" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-San Diego Zion" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IVA Lung Cancer AJCC v8" (7 trials) and "Stage IVB Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Kaiser Permanente-San Diego Zion" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-San Diego Zion" are "Drug" (91 trials), "Other" (81 trials), "Biological" (60 trials), "Procedure" (35 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (28 trials), "Biospecimen Collection" (19 trials), "Computed Tomography" (19 trials) and "Nivolumab" (18 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-San Diego Zion" are 104 trials for "All" genders, 16 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-San Diego Zion". undefined are not yet recruiting, 23 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Kaiser Permanente-San Diego Zion, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-San Diego Zion, 0 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".